Topics

Nexstim Plc: The final outcome of the subscription rights issue of Nexstim Plc

13:30 EDT 2 May 2019 | GlobalNewsWire (2014)
This article has expired, however you can still download the PDF.
Preview:
Company announcement, Helsinki, 2 May 2019 at 6.30 PM Nexstim Plc: The final outcome of the subscription rights issue of Nexstim Plc NOT TO BE PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY TO THE UNITED STATES OF AMERICA, CANADA, NEW ZEAL...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Nexstim Plc: The final outcome of the subscription rights issue of Nexstim Plc"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...